The Ca2+/calmodulin-dependent kinase (CaMK) family has been recognized as a key mediator in living organisms and various biological processes.
CaMK II is a multifunctional cytoplasmic calcium and calmodulin-dependent protein kinase that phosphorylates and alters the function of a variety of substrates. The CaMK II pathway has been found to regulate the RANKL-induced osteoclast formation via the cAMP-response element binding protein (CREB) pathway.
Among many signaling pathways of proliferation, intracellular calciumol/L has been extensively demonstrated to be very important. In cytoplasm, calciumol/L binds to calmodulin, and then activates the CaMKs which are a family of structurally related serine/threonine protein kinases including CaMKI-IV. CaMKII, a multi functional protein kinase, is ubiquitously involved in many physiological processes including control of cell cycle, apoptosis, gene expression, and neurotransmission.
BRD0418 是一种调节三元假激酶1 (TRIB1) 表达的多样化综合 (DOS) 分子,具有使热脂蛋白代谢从脂肪生成转向清除的作用,可用于冠状动脉疾病 (CAD) 的研究。
CaMKI (299-320) 是由钙/钙调蛋白依赖性蛋白激酶 I(Calcium/calmodulin-dependent protein kinase I,简称 CaMKI)第 299 至 320 位氨基酸残基组成的肽段,作为蛋白激酶与 Ca2+–CaM 具有高亲和力(Kd≤1 nM),能够磷酸化特定底物蛋白从而调节其活性,并包含 CaM 结合域和自我抑制域,可用于细胞增殖、分化和凋亡(apoptosis)等细胞生理过程的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号